NASDAQ · Healthcare · Biotechnology
Parabilis Medicines, Inc.
PBLS
Fog Pharmaceuticals, Inc. CEO Mathai Mammen · Market cap $4.6B.
$39.36
-0.22 · -0.56%
52w hi $41.4952w lo $24.51
Off 52w high 10.6%
86
STRONG
Current InsiderScore
Corp · 90d
14
14 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
4
2 strong · 2 notable
Analyst consensus
—
Avg PT $40.00
Section 01
Recent Form 4 filings
14 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jul 22 | RA CAPITAL MANAGEMENT, L.P. | Buy | 47,250 | $29.77 | +$1.41M | 46 | |
| Jul 21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 6,504 | $29.17 | +$190K | 40 | |
| Jul 21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 21,696 | $27.96 | +$607K | 43 | |
| Jul 21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 37,723 | $30.00 | +$1.13M | 46 | |
| Jul 20 | RA CAPITAL MANAGEMENT, L.P. | Buy | 32,987 | $27.72 | +$914K | 43 | |
| Jul 20 | RA CAPITAL MANAGEMENT, L.P. | Buy | 98,433 | $27.13 | +$2.67M | 46 | |
| Jun 15 | Alan Sebulsky | Buy | 5,000 | $26.00 | +$130K | 48 | |
| Jun 15 | Alan Sebulsky | Buy | 4,065 | $27.10 | +$110K | 48 | |
| Jun 12 | Alan Sebulsky | Buy | 8,435 | $27.67 | +$233K | 55 | |
| Jun 11 | Alan Sebulsky | Buy | 12,500 | $20.00 | +$250K | 73 | |
| Jun 11 | RA CAPITAL MANAGEMENT, L.P. | Buy | 19,728,353 | $20.00 | +$394.57M | 86 | |
| Jun 11 | RA CAPITAL MANAGEMENT, L.P. | Buy | 1,460,397 | $20.00 | +$29.21M | 86 | |
| Jun 11 | Guy Levy | Buy | 375,000 | $20.00 | +$7.50M | 68 | |
| Jun 11 | Guy Levy | Buy | 125,000 | $20.00 | +$2.50M | 58 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug